HealthFDA Under Fire for Greenlighting Controversial Opioid Addiction Genetic Test 'AvertD' Amid Opioid Crisis FDA faces backlash over approval of AvertD genetic test for opioid addiction risk. Concerns arise about efficacy and the potential impact on prescribing practices.by John Lopez
HealthFDA Approves Oliceridine, An Intravenous Opioid Severe Acute Pain Relievers for Clinical Useby Isaiah Alonzo
HealthCan Brain Implants Treat Drug Addicts? Chinese Doctors Use Eye Deep Brain Stimulation For Opioid Addiction Treatmentby Alyssa Navarro
TechInstagram Offers Support Against Opioid Addiction When Users Search For Drugsby John Carlo A. Villaruel
HealthRetail Stores Install Blue Lights In Restrooms To Try To Fight Back Against Opioid Epidemicby Aaron Mamiit
HealthChildren More Likely To Experience Serious Side Effects From Hydrocodone-Based Cold Medicinesby Sami Ghanmi
HealthFor Doctors, More Opioid Prescriptions Mean Bigger Payouts, Says Harvard Analysisby Carl Velasco